Prestige EquiRab

RABIES VACCINE, KILLED VIRUS

A liquid suspension of inactivated rabies virus propagated in a stable cell line.

Prestige EquiRab Indications

This product has been shown to be effective for the vaccination of healthy horses 4 months of age or older against rabies virus. Duration of immunity for Rabies is at least 14 months. For more information regarding safety and efficacy data, go to productdata.aphis.usda.gov.

DOSE: For primary vaccination aseptically administer 1 mL intramuscularly. Revaccinate in one year and every 14 months afterwards. For advice on revaccination in the face of stress or an exposure, consult your veterinarian.

CAUTIONS: Store at 2°-8°C (35°-46°F). Do not freeze. Shake well before using. Use entire contents when first opened. Do not mix with other products. This product has not been tested in pregnant animals. Do not vaccinate within 21 days before slaughter. Vaccinating animals whose immune response is compromised by stress, disease, etc. may not produce the desired results. Anaphylactic reactions may occur. If allergic reaction occurs, treat with epinephrine. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. In case of human exposure, contact a physician.

ANTIBIOTICS: Neomycin and polymixin B.

PRESERVATIVE: Thimerosal.

FOR ANIMAL USE ONLY

Intervet Inc. d/b/a Merck Animal Health, Omaha, NE 68103, USA

VLN 165A/PCN 1905.23

1 800 521-5767 (USA)

1 866 683-7838 (CAN)

For patent information:

http://www.merck.com/product/patent/home.html

CPN: 1047551.1